je.st
news
Tag: cancer
FDA Approves KEYTRUDA (pembrolizumab) for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Containing Chemotherapy
2015-10-02 20:49:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Patients with EGFR or ALK Genomic Tumor Aberrations Should Have Disease Progression on FDA-Approved Therapy for These Aberrations Prior to Receiving KEYTRUDA KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab) monotherapy, the companys anti-PD-1 (programmed death receptor-1) therapy, at a dose of 2 mg/kg every three weeks, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express PD-L1 as determined by an FDA-approved test and who have disease progression on or after platinum-containing chemotherapy. Language: English Contact: MerckMedia Contacts:Pamela Eisele, 267-305-3558Courtney Ronaldo, 908-236-1108orInvestor Contacts:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: or
express
cell
treatment
Barbadians urged to embrace Breast Cancer cause
2015-10-02 13:48:46| Apparel - Topix.net
This October, Barbadians can " Embrace the Cause " and join Payless ShoeSource and the Breast Screening Programme of The Barbados Cancer Society in the fight against breast cancer with the purchase of a 2015 Payless Breast Cancer Awareness bracelet. The latest in an annual series of tastefully designed accessory bracelets from Payless ShoeSource - featuring the iconic pink ribbon - will go on sale from October 1st at all Payless ShoeSource Stores in Barbados.
Tags: cancer
breast
urged
embrace
Skechers Performance Partners for a Second Year with American Cancer...
2015-10-02 05:20:08| Apparel - Topix.net
Skechers Performance, a division of SKECHERS USA, Inc. , is thrilled to announce its 2015 partnership with the American Cancer Society to help in the fight to end breast cancer. For the second year in a row, Skechers Performance will launch a month-long marketing program that includes in-store, digital and print executions, as well as the sponsorship of the American Cancer Society Making Strides Against Breast Cancer walk in San Francisco.
Tags: with
year
american
performance
Bristol-Myers' gets early approval of combo cancer treatment
2015-10-01 20:40:07| Biotech - Topix.net
The first combination of breakthrough drugs that boost the immune system to fight cancer has been approved, giving maker Bristol-Myers Squibb an early lead over competitors testing their own combos in a pharmaceutical gold rush of sorts. The Food and Drug Administration has given accelerated approval to a regimen combining the New York-based drugmaker's two immuno-oncology drugs, Opdivo and Yervoy, to treat patients with advanced melanoma who have a particular genetic variation.
Tags: early
treatment
approval
cancer
Skechers Performance Partners for a Second Year with American Cancer...
2015-10-01 17:03:46| Footwear - Topix.net
Skechers Performance, a division of SKECHERS USA, Inc. , is thrilled to announce its 2015 partnership with the American Cancer Society to help in the fight to end breast cancer. For the second year in a row, Skechers Performance will launch a month-long marketing program that includes in-store, digital and print executions, as well as the sponsorship of the American Cancer Society Making Strides Against Breast CancerA walk in San Francisco.
Tags: with
year
american
performance
Sites : [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] next »